Biotechnology Reagents & Kits Market

Biotechnology Reagents & Kits Market by Kit Types (Purification Kits, Amplification Kits, Detection Kits, Isolation Kits, and Others), Technology (LAMP Technology, PCR, Cell Culture, Sequencing, Chromatography, Electrophoresis, Flow Cytometry, and Other), Tested Parameters (DNA, RNA, Enzymes, Proteins, and Others), Micro-organisms (Bacteria, Virus, Fungi, and Parasites), Purposes (On-site and Laboratory), End-users (Healthcare, Food & Agriculture, Natural Resources & Environment, Industrial Processing, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028.

  • Report ID: CG-2520
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 2
  • No. Of Pages: 194
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global biotechnology reagents & kits market size was valued at USD 337.28 billion in 2020 and is anticipated to expand at a CAGR of 16.1% during the forecast period, 2021–2028. The growth of the market is attributed to the rising advancements in the technologies and research activities, growing molecular biology application, and increasing demand of biotechnology.

Biotechnology Reagents & Kits Market summary

Biotechnology reagents are compounds or substances that are used to synthesize or detect other compound to give a reading of test. These reagents have application in the field of diagnosis, research, education, and bioscience. The Biotechnology reagents utilize technology such as spectrometry, cell culture, IVD, flow cytometry, chromatography, expression and transfection, PCR, and electrophoresis. The development in several engineering tools, molecular biology field, and approaches are established to meet the growing demand in the market. Increasing research in molecular biology has boosted the application of biotechnology reagents & kits in the recent times. The advancements in the arena of genomic sequencing in the past few years has also propelled the market growth. Over the past few years, the high technological advancements in the areas such as big-data analysis & storage, genome engineering, high-throughput sequencing, and gene therapy.

The COVID-19 pandemic outbreak showed a positive growth in the market as the use of biotechnology reagents were widely used for development of COVID-19 diagnosis. The research on the COVID-19 detection showed that the flow cytometry-based method was a potential candidate for COVID-19 testing. Scientists utilize the method for detecting the types of T cells that are released in the body for immune response against COVID-19 virus. This result upsurge the use of flow cytometry reagents & kits, and propelled the market. RT-PCR assay technique is widely used method for diagnosis of viral RNA in COVID-19 suspected patients. The Center for Disease Control (CDC) has set a protocol for use and validation of various kits for the extraction of nucleic acid. Isolation of nucleic acids is an integral part of the COVID-19 testing workflow.

Market Trends, Drivers, Restraints, and Opportunities

  • Heavy investments by the biotechnology companies in research and development, rise in the biopharmaceuticals, increasing quantity of biotechnology firms, and advancement of technology are anticipated to bolster the market in the near future.
  • Rising commercial applications, increasing number of the protein profiling, as well as the growing use of biotechnology reagents in therapeutics are expected to boost the market growth.
  • Inclusion of environmental implementations and stem cell research are the key factors expected to fuel the market growth during the forecast period.
  • High cost of biopharmaceuticals is anticipated to act as a restraint for the market during the projected period.
  • Rising demand for purification kits and nucleic acid isolation is offering new opportunities for the market expansion in the near future.

Scope of the Report

The report on the global biotechnology reagents & kits market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Biotechnology Reagents & Kits Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Kit Types (Purification Kits, Amplification Kits, Detection Kits, Isolation Kits, and Others), Technology (LAMP Technology, PCR, Cell Culture, Sequencing, Chromatography, Electrophoresis, Flow Cytometry, and Other), Tested Parameters (DNA, RNA, Enzymes, Proteins, and Others), Micro-organisms (Bacteria, Virus, Fungi, and Parasites), Purposes (On-site and Laboratory), and End-users (Healthcare, Food & Agriculture, Natural Resources & Environment, Industrial Processing, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Thermo Fisher Scientific; QIAGEN; New England Biolabs; Illumina, Inc.; Agilent Technologies, Inc.; Bio-Rad Laboratories; F. Hoffmann-La Roche Ltd.; Merck KGaA; Promega Corp.; Takara Bio, Inc.; LGC Ltd.; and Toyobo Co. Ltd.

Market Segment Insights

Detection kits segment is expected to grow at a robust pace

Based on kit types, the global biotechnology reagents & kits market is divided into purification kits, amplification kits, detection kits, isolation kits, and others. The detection kits segment is estimated to grow at a robust pace during the forecast period owing to the COVID-19 outbreak and use of detection kits in diagnosis of COVID-19. The increase in the demand for detection kits has tremendously boosted the production and sells of the kits in the recent months. The other sections of application of these kits are industrial processing, food, healthcare, and agriculture.

Biotechnology Reagents & Kits Market types

The Defence Institute of Physiology and Allied Sciences (DIPAS) and the Defence Research and Development Laboratory in May 2021 launched a kit which is antibody-dependent named as DIPCOVAN DIPAS-VDx. These kits are able to identify both nuceleocapsid and spikes proteins of the COVID-19 virus with nearly 99% specificity and 97% sensitivity. The molecular diagnostics is a key contributing segment in the coming years due to rising demand for the diagnostics. The RT-PCR-based kits is a part of molecular diagnostics has gained huge demand in the pandemic and hence the growth chart of the segment in inclining.

Cell culture technology segment is projected to expand at a considerable CAGR

On the basis of technology, the market is segmented into lamp technology, PCR, cell culture, sequencing, chromatography, electrophoresis, flow cytometry, and other. The Cell culture technology segment is projected to expand at a considerable CAGR during the forecast period attributed to the high demand and extensive R&D activities in the field. The biotechnology companies are adopting to the segment, which is boosting the growth rate of the segment.

The PCR is the second high grossing segment in the market as the technique is highly effective for the analysis and detection of gene sequences. The genomic studies utilize this technique due to its high effectiveness as well as accurate results. The COVID-19 pandemic has also increased the use of PCR for the detection of virus. Next-generation Sequencing (NGS) is also a segment with considerable market growth opportunities as it is a strong tool for characterization of cell line as well as it is a reliable technique. It has its application in gene therapy, recombinant proteins, and vaccines.

RNA segment is projected to grow at a substantial rate

In terms of tested parameters, the global biotechnology reagents & kits market is classified into DNA, RNA, enzymes, proteins, and others. The RNA segment is projected to grow at a substantial rate in the coming years due to rising research and development of improved techniques. Growing interest of universities and companies to develop the RNA-based therapeutics is boosting the market growth. Meanwhile, the DNA segment is expected to exhibit fast growth pace as it has various applications in pharmacogenomics diagnostic testing, newborn genetic screening, identity diagnostics & forensics, and drug metabolism.

Virus segment is anticipated to expand at a significant growth rate

On the basis of micro-organisms, the market is divided into bacteria, virus, fungi, and parasites. The virus segment is anticipated to expand at a significant growth rate during the projected period owing to the wide application of virus-based clinical testing in the field of vaccines as well as gene therapy development. Rising research and development activities in the use of virus as a vector in the vaccine development is a key factor for the dominance of this segment in the market. Moreover, the COVID-19 outbreak has significantly contributed for the segment improvement as the demand for viral reagent was increased in the period.
The bacterial segment accounted for a large revenue share in 2019 and is anticipated to hold a key market share in the coming years attributed to the use of bacteria in the cancer management. Bacteria’s ability to work as an anti-cancer agent is the major driving factor for the segment in the coming time period.

On-site segment is estimated to exhibit a considerable growth rate

On the basis of purposes, the global biotechnology reagents & kits market is bifurcated into on-site and laboratory. The on-site segment is estimated to exhibit a considerable growth rate owing to increase in Point-of-Care (POC) testing as well as accurate and quick POC testing. The segment has its extensive applications in the beverage and food industry. The on-site testing includes enzymatic and microbiological testing. The enzymatic o-site testing measures the constituents as alcohol, sugar, and acid in food. The microbiological on-site testing has its application in identification of bacteria, molds, and virus in food.
The laboratory reagent segment, however, is expected to grow substantially in the coming years owing to the presence of several methodologies and assays which are flow cytometry, support Immunohistochemistry (IHC), protein purification, cell culture, cell selection, immunodepletion, and others. 

Healthcare segment is projected to expand at a fast pace

Based on end-users, the market is segmented into healthcare, food & agriculture, natural resources & environment, industrial processing, and others. The healthcare segment is projected to expand at a fast pace during the projected period and represented with more than 50% of the global revenue share in 2019. This is because of extensive R&D and clinical trials for clinical diagnostics as well as rising number of collaborations and mergers of the key market players. On the other hand, the food & agriculture segment is expected to boost rapidly in the near future owing to the use biotechnological tools in plants and animals for improving their yield, color, and size.

North America is anticipated to constitute a key market share

In terms of regions, the global biotechnology reagents & kits market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to constitute a key market share during the forecast period owing to the well-developed healthcare facilities as well as extensive high quality research and presence of skilled professionals. Furthermore, the high number of novel product development and the presence of new major companies in the region play key roles in the regional market development.  

Biotechnology Reagents & Kits Market region

Meanwhile, the market of Asia Pacific is anticipated to grow at an impressive  pace as high disposable income of a large number of the population, rising research activities, and development of therapeutic and diagnostic infrastructure in the region.

 

Segments

Segments Covered in the Report

The global biotechnology reagents & kits market has been segmented on the basis of

Kit Types

  • Purification Kits
  • Amplification Kits
  • Detection Kits
  • Isolation Kits
  • Others

Technology

  • LAMP Technology
  • PCR
  • Cell Culture
  • Sequencing
  • Chromatography
  • Electrophoresis
  • Flow Cytometry
  • Others

Tested Parameters

  • DNA
  • RNA
  • Enzymes
  • Proteins
  • Others

Micro-organisms

  • Bacteria
  • Virus
  • Fungi
  • Parasites

Purposes

  • On-site
  • Laboratory

End-users

  • Healthcare
  • Food & Agriculture
  • Natural Resources & Environment
  • Industrial Processing
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Thermo Fisher Scientific
  • QIAGEN
  • New England Biolabs
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA; Promega Corp.
  • Takara Bio, Inc.
  • LGC Ltd.
  • Toyobo Co. Ltd.

Competitive Landscape

The key market players in the global biotechnology reagents & kits market are Illumina, Inc.; Thermo Fisher Scientific; QIAGEN; New England Biolabs; Takara Bio, Inc.; Bio-Rad Laboratories; F. Hoffmann-La Roche Ltd.; Agilent Technologies, Inc.; Merck KGaA; Promega Corp.; LGC Ltd.; and Toyobo Co. Ltd.
In March 2021, GenMark diagnostics and Roche made a merger agreement to launch a technology which aimed to detect various pathogen in a one sample of patient blood. New England BioLab, Inc. introduced the Luna SARS-CoV-2 RT-qPCR Assay Kit in January 2021, for the identification of SARS-CoV-2 nucleic acid.

Biotechnology Reagents & Kits Market keyplayers

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Biotechnology Reagents & Kits Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Biotechnology Reagents & Kits Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Biotechnology Reagents & Kits Market - Supply Chain
  4.5. Global Biotechnology Reagents & Kits Market Forecast
     4.5.1. Biotechnology Reagents & Kits Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Biotechnology Reagents & Kits Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Biotechnology Reagents & Kits Market Absolute $ Opportunity
5. Global Biotechnology Reagents & Kits Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Biotechnology Reagents & Kits Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Biotechnology Reagents & Kits Demand Share Forecast, 2019-2026
6. North America Biotechnology Reagents & Kits Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Biotechnology Reagents & Kits Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Biotechnology Reagents & Kits Demand Share Forecast, 2019-2026
7. Latin America Biotechnology Reagents & Kits Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Biotechnology Reagents & Kits Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Biotechnology Reagents & Kits Demand Share Forecast, 2019-2026
8. Europe Biotechnology Reagents & Kits Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Biotechnology Reagents & Kits Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Biotechnology Reagents & Kits Demand Share Forecast, 2019-2026
9. Asia Pacific Biotechnology Reagents & Kits Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Biotechnology Reagents & Kits Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Biotechnology Reagents & Kits Demand Share Forecast, 2019-2026
10. Middle East & Africa Biotechnology Reagents & Kits Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Biotechnology Reagents & Kits Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Biotechnology Reagents & Kits Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Biotechnology Reagents & Kits Market: Market Share Analysis
  11.2. Biotechnology Reagents & Kits Distributors and Customers
  11.3. Biotechnology Reagents & Kits Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Thermo Fisher Scientific
     11.4.2. QIAGEN
     11.4.3. New England Biolabs
     11.4.4. Illumina, Inc.
     11.4.5. Agilent Technologies, Inc.
     11.4.6. Bio-Rad Laboratori

Segments Covered in the Report

The global biotechnology reagents & kits market has been segmented on the basis of

Kit Types

  • Purification Kits
  • Amplification Kits
  • Detection Kits
  • Isolation Kits
  • Others

Technology

  • LAMP Technology
  • PCR
  • Cell Culture
  • Sequencing
  • Chromatography
  • Electrophoresis
  • Flow Cytometry
  • Others

Tested Parameters

  • DNA
  • RNA
  • Enzymes
  • Proteins
  • Others

Micro-organisms

  • Bacteria
  • Virus
  • Fungi
  • Parasites

Purposes

  • On-site
  • Laboratory

End-users

  • Healthcare
  • Food & Agriculture
  • Natural Resources & Environment
  • Industrial Processing
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Thermo Fisher Scientific
  • QIAGEN
  • New England Biolabs
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA; Promega Corp.
  • Takara Bio, Inc.
  • LGC Ltd.
  • Toyobo Co. Ltd.

The key market players in the global biotechnology reagents & kits market are Illumina, Inc.; Thermo Fisher Scientific; QIAGEN; New England Biolabs; Takara Bio, Inc.; Bio-Rad Laboratories; F. Hoffmann-La Roche Ltd.; Agilent Technologies, Inc.; Merck KGaA; Promega Corp.; LGC Ltd.; and Toyobo Co. Ltd.
In March 2021, GenMark diagnostics and Roche made a merger agreement to launch a technology which aimed to detect various pathogen in a one sample of patient blood. New England BioLab, Inc. introduced the Luna SARS-CoV-2 RT-qPCR Assay Kit in January 2021, for the identification of SARS-CoV-2 nucleic acid.

Biotechnology Reagents & Kits Market keyplayers

Buy Report